eQTLs | mQTLs | meQTLs | Random SNPs | p-value eQTLs | p-value mQTLs | p-value meQTLs | p-adjusted eQTLs | p-adjusted mQTLs | p-adjusted meQTLs | Association | Name | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Total number | 31,482 | 246,758 | 6850 | 150,000 | – | – | – | – | – | – | – | – | |
Conservation | GERP | 1049 (3.66%) | 8112 (3.59%) | 148 (2.35%) | 6349 (4.65%) | 5.04e−14 | 2.36e−55 | 8.57e−21 | – | – | – | – | – |
Siphy | 716 (2.5%) | 5305 (2.35%) | 116 (1.84%) | 3619 (2.65%) | 1.43e−01 | 1.29e−08 | 4.42e−05 | – | – | – | – | – | |
Chromatin states | 1_TssA | 195 (0.68%) | 1057 (0.47%) | 32 (0.51%) | 222 (0.16%) | 1.03e−43 | 8.55e−57 | 1.19e−07 | 1.74e−42 | 1.45e−55 | 2.03e−06 | Promoter-associated | Active transcription start site |
2_PromU | 203 (0.71%) | 1598 (0.71%) | 62 (0.98%) | 766 (0.56%) | 3.78e−03 | 9.90e−08 | 8.23e−05 | 6.42e−02 | 1.68e−06 | 1.40e−03 | Promoter-associated | Promoter upstream transcription start site | |
3_PromD1 | 138 (0.48%) | 841 (0.37%) | 68 (1.08%) | 375 (0.27%) | 6.39e−08 | 7.11e−07 | 5.56e−19 | 1.09e−06 | 1.21e−05 | 9.46e−18 | Promoter-associated | Promoter downstream transcription start site 1 | |
4_PromD2 | 129 (0.45%) | 1195 (0.53%) | 31 (0.49%) | 300 (0.22%) | 1.01e−10 | 5.71e−49 | 1.23e−04 | 1.72e−09 | 9.71e−48 | 2.10e−03 | Promoter-associated | Promoter downstream transcription start site 2 | |
22_PromP | 90 (0.31%) | 924 (0.41%) | 29 (0.46%) | 306 (0.22%) | 6.32e−03 | 1.71e−21 | 6.99e−04 | 1.08e−01 | 2.91e−20 | 1.19e−02 | Promoter-associated | Poised promoter | |
23_PromBiv | 218 (0.76%) | 2482 (1.1%) | 47 (0.75%) | 1227 (0.9%) | 2.33e−02 | 5.59e−09 | 2.18e−01 | 3.96e−01 | 9.51e−08 | 1.00e + 00 | Promoter-associated | Bivalent promoter | |
10_TxEnh5 | 299 (1.04%) | 2394 (1.06%) | 83 (1.32%) | 542 (0.4%) | 1.08e−36 | 4.22e−114 | 8.44e−19 | 1.83e−35 | 7.17e−113 | 1.44e−17 | Enhancer-associated | Transcribed 5′preferential and enhancer | |
11_TxEnh3 | 417 (1.46%) | 2332 (1.03%) | 92 (1.46%) | 474 (0.35%) | 7.80e−92 | 5.23e−129 | 5.68e−27 | 1.33e−90 | 8.89e−128 | 9.66e−26 | Enhancer-associated | Transcribed 3′preferential and enhancer | |
12_TxEnhW | 171 (0.6%) | 840 (0.37%) | 21 (0.33%) | 259 (0.19%) | 5.81e−28 | 2.28e−23 | 1.86e−02 | 9.87e−27 | 3.87e−22 | 3.15e−01 | enhancer-associated | Transcribed and weak enhancer | |
13_EnhA1 | 219 (0.76%) | 1165 (0.52%) | 111 (1.76%) | 365 (0.27%) | 4.68e−31 | 9.22e−31 | 1.30e−47 | 7.96e−30 | 1.57e−29 | 2.21e−46 | Enhancer-associated | Active enhancer 1 | |
14_EnhA2 | 124 (0.43%) | 1554 (0.69%) | 54 (0.86%) | 388 (0.28%) | 8.46e−05 | 6.00e−64 | 2.32e−11 | 1.44e−03 | 1.02e−62 | 3.95e−10 | Enhancer-associated | Active enhancer 2 | |
15_EnhAF | 139 (0.49%) | 1421 (0.63%) | 30 (0.48%) | 434 (0.32%) | 3.16e−05 | 1.78e−39 | 4.04e−02 | 5.38e−04 | 3.02e−38 | 6.87e−01 | enhancer-associated | Active enhancer flank | |
16_EnhW1 | 155 (0.54%) | 1136 (0.5%) | 23 (0.37%) | 271 (0.2%) | 7.73e−21 | 9.90e−51 | 9.47e−03 | 1.31e−19 | 1.68e−49 | 1.61e−01 | Enhancer-associated | Weak enhancer 1 | |
17_EnhW2 | 247 (0.86%) | 1963 (0.87%) | 26 (0.41%) | 580 (0.43%) | 8.48e−19 | 3.79e−58 | 1.00e + 00 | 1.44e−17 | 6.44e−57 | 1.00e + 00 | Enhancer-associated | Weak enhancer 2 | |
18_EnhAc | 110 (0.38%) | 767 (0.34%) | 32 (0.51%) | 284 (0.21%) | 2.27e−07 | 3.67e−13 | 1.43e−05 | 3.86e−06 | 6.24e−12 | 2.43e−04 | Enhancer-associated | Primary H3K27ac–possible enhancer | |
9_TxReg | 129 (0.45%) | 1274 (0.56%) | 21 (0.33%) | 807 (0.59%) | 3.24e−03 | 2.97e−01 | 6.42e−03 | 5.50e−02 | 1.00e + 00 | 1.09e−01 | Promoter/enhancer associated | Transcribed and regulatory | |
19_DNase | 110 (0.38%) | 948 (0.42%) | 38 (0.6%) | 404 (0.3%) | 1.68e−02 | 2.31e−09 | 1.06e−04 | 2.85e−01 | 3.93e−08 | 1.80e−03 | Promoter/enhancer associated | Primary DNase | |
Histone marks | H3K4me3_Pro | 3322 (11.6%) | 27,570 (12.21%) | 775 (12.3%) | 7896 (5.79%) | 7.20e−242 | 0.00e + 00 | 2.25e−79 | 2.88e−241 | 0.00e + 00 | 9.00e−79 | Promoter-associated | Histone H3 lysine 4 trimethylation |
H3K9ac_Pro | 4356 (15.21%) | 30,036 (13.3%) | 1207 (19.16%) | 10,517 (7.71%) | 7.45e−313 | 0.00e + 00 | 1.21e−175 | 2.98e−312 | 0.00e + 00 | 4.83e−175 | Promoter-associated | Histone H3 lysine 9 acetylation | |
H3K4me1_Enh | 3019 (10.54%) | 22,816 (10.1%) | 794 (12.6%) | 5877 (4.31%) | 0.00e + 00 | 0.00e + 00 | 7.46e−146 | 0.00e + 00 | 0.00e + 00 | 2.98e−145 | Enhancer-associated | Histone H3 lysine 4 monomethylation | |
H3K27ac_Enh | 5179 (18.08%) | 43,529 (19.27%) | 1097 (17.41%) | 14,640 (10.73%) | 1.83e−241 | 0.00e + 00 | 5.42e−54 | 7.31e−241 | 0.00e + 00 | 2.17e−53 | Enhancer-associated | Histone H3 lysine 27 acetylation | |
eQTLs | eQTLs | 20,199 (70.53%) | 52,029 (23.04%) | 5370 (85.22%) | 6452 (4.73%) | 0.00e + 00 | 0.00e + 00 | 0.00e + 00 | – | – | – | – | – |